ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The Src kinases sustain the proliferation of BCR-ABL expressing cells, the transition of CML to lymphoid blast crisis [33,34,35], and in some cases, the overexpression of Src kinases have been implicated in Imatinib acquired resistance [7,8].